CODE KENNETH REAY (Chief Science Officer) received a stock award from BIOLARGO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/17/2025ACC: 0001437749-25-035504
DirectorOfficer10% Owner· Chief Science Officer
Since Jul 2018
+313.75K
Net shares
Net buyer
$50.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
313.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+313.75K
Price / share
$0.16
Trade value
$50.20K
% of position
1.2%
11/14/2025
25.44M→25.75M
Total
Net shares
+313.75K
Net value
$50.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/14/2025 | A · Award | +313.75K | $0.16 | $50.20K | 1.2% | 25.44M | 25.75M |
| Total | +313.75K | $50.20K | ||||||
Derivative Transactions0
No derivative transactions reported